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ABSTRACT
Background This is a study of the relationships
between common reasons for encounter (RfEs) and
common diagnoses (episode titles) within episodes
of care (EoCs) in family practice populations in
four countries.
Method Participating family doctors (FDs) recorded
details of all their patient contacts in an EoC
structure using the International Classiﬁcation of
Primary Care (ICPC), including RfEs presented by
the patient, and the FDs’ diagnostic labels. The
relationships between RfEs and episode titles were
studied using Bayesian methods.
Results The RfE ‘cough’ is a strong, reliable pre-
dictor for the diagnoses ‘cough’ (a symptom diag-
nosis), ‘acute bronchitis’, ‘URTI’ and ‘acute
laryngitis/tracheitis’ and a less strong, but reliable
predictor for ‘sinusitis’, ‘pneumonia’, ‘inﬂuenza’,
‘asthma’, ‘other viral diseases (NOS)’, ‘whooping
cough’, ‘chronic bronchitis’, ‘wheezing’ and ‘phlegm’.
The absence of cough is a weak but reliable predic-
tor to exclude a diagnosis of ‘cough’, ‘acute bron-
chitis’ and ‘tracheitis’. Its presence allows strong and
reliable exclusion of the diagnoses ‘gastroenteritis’,
‘no disease’ and ‘health promotion/prevention’, and
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Introduction
The development of family medicine (FM, synony-
mous with general practice) as a clinical speciality and
an academic discipline is informed and enhanced by
the collection of empirical longitudinal data from
routine clinical practice. The study of the epidemi-
ology of FM using electronic medical record (EMR)
databases represents a classic example, empirically
measuring the content of actual practice and inform-
ing FM research, education, policy planning and
clinical practice.1,2
The International Classiﬁcation of Primary Care
(ICPC) acts as an ordering principle for FM data,
allowing for direct international comparisons, and has
the appropriate granularity for primary care.3,4 In the
Transition Project, such ICPC data have been col-
lected with EMRs in the Netherlands, Japan, Poland,
Malta, Serbia and other countries from the daily
practice of a cohort of family doctors (FDs) using a
similar methodology over time (1 to 11 years). 5–11
Use of the ICPC to study the epidemiology of FM
has the advantage of allowing precise capture of reason
for encounter data, often ignored in FM research,2,11–
13 and this allows further important perspectives into
the process of diagnosis in FM.
This study aims to support the academic develop-
ment of FM through the study of the content of
episodes of care for two common symptoms in FM,
‘cough’ and ‘sadness’ or ‘feeling depressed’. The study
aims to exemplify how data such as those from the
Transition Project may be used to explore the process
of diagnosis from a symptom, rather than from a
disease, perspective.
The research question for this study is: ‘What are the
quantitative relationships between common reasons for
encounter and common diagnoses (episode titles)
within episodes of care in routine family practice in
practice populations from Malta, the Netherlands,
Serbia and Japan, as exempliﬁed by the reasons for
encounter ‘cough’ and ‘sadness/feeling depressed?’
Method
The public-domain EMRTransHis,10 designed for use
with ICPC, was used to collect data from participating
FDs who recorded details [reason(s) for encounter,
diagnosis(es) and intervention(s)] of all their patient
contacts in an episode of care (EoC) structure using
ICPC. Reasons for encounter presented by the patient,
all FD interventions and the diagnostic labels recorded
for each encounter were classiﬁed as recommended
with ICPC (ICPC-2-E in Malta and Serbia, ICPC-1 in
the Netherlands and Japan). All encounter data (face-
to-face encounters in the oﬃce and at home, tele-
phone consultations, repeat prescriptions, etc.) were
analysed in an EoC structure to obtain complete data
on incidence and prevalence, including patients pre-
senting for a repeat prescription only.
An EoC is deﬁned as a health problem from its ﬁrst
presentation by the patient to the FD, until the com-
pletion of the last encounter for it. It encompasses all
contact elements related to that health problem. Its
name (i.e. the diagnostic label of the EoC) may be
modiﬁed over time, and in this article we refer to it as
the episode title. The last diagnosis made during an
EoC is the current episode title.4
The reason(s) for encounter (RfEs) is deﬁned as an
agreed statement of the reason(s) why a person enters
the healthcare system, representing the demand for
care by that person. The RfE should be recognised by
the patient as an acceptable description of the demand
for care.4,14,15 FDs recording data for the Transition
Project were trained to record RfEs according to the
deﬁnitions above and the recommendations in the
ICPC book,4 reﬂecting the patient’s symptoms and
less strong exclusion of ‘adverse eﬀects of medi-
cation’. The RfE ‘sadness’ is a strong, reliable
predictor for the diagnoses ‘feeling sad/depressed’
and ‘depressive disorder’. It is a less strong, but
reliable predictor of a diagnosis of ‘acute stress
reaction’. The absence of sadness (as a symptom)
is a weak but reliable predictor to exclude the
symptomdiagnosis ‘feeling sad/depressed’. Its pres-
ence does not support the exclusion of any diag-
nosis.
Conclusions We describe clinically and statisti-
cally signiﬁcant diagnostic associations observed
between the RfEs ‘cough’ and ‘sadness’, presenting
as a new problem in family practice, and all the
episode titles in ICPC.
Keywords: cough, depressed, diagnosis, electronic
medical record, electronic patient record, episode
of care, family medicine, general practice, ICPC,
International Classiﬁcation of Primary Care, inter-
national, Japan, Malta, posterior probability, prior
probability, reason for encounter, sadness, Serbia,
symptom, The Netherlands, Transition Project
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requests as expressed. Symptoms elicited during his-
tory-taking (i.e. the history of the presenting com-
plaint) were recorded in a separate cell in the EMR
TransHis, but were not included in the analyses in this
study.
The four databases each encompass a deﬁned period:
an average of 9896 patients and 43 577 patient years of
observation over ﬁve years in Malta (2001–2005),
15 318 patients and 158 370 patient years over 11 years
in the Netherlands (1995–2005), 72 673 patient years
over one year in Serbia (2003) and 17 042 patient years
over three years in Japan (1996–1998). The practice
populations in the Netherlands, Serbia and Japan
represent registered patient populations (only those
over 15 years of age in Serbia), whereas the population
in Malta represents patients consulting over a ﬁve-
year period. The databases were analysed using a one-
year data-frame for the purpose of calculating inci-
dence and prevalence rates.
The relationships between RfEs and episode titles
were studied using Bayesian probabilistic methods.
According to Bayes’ Theorem, the post-test (pos-
terior) odds of an event (i.e. a speciﬁc diagnosis being
made) are equivalent to the pre-test odds multiplied
by the likelihood ratio (LR). The LRs presented in the
tables were calculated in a method similar to that used
byOkkes et al.8,16 The LRwas calculated for a problem
presenting for the ﬁrst time at the beginning of a new
EoC.Wemodiﬁed themethod slightly to calculate LRs
for an EoC, rather than for patient years of obser-
vation.
The LR is amathematical expression of the extent to
which a symptom increases the probability of a diag-
nosis. The (positive) LR (LR+) for the existence of the
symptom is the odds that it will exist in a patient with
the disease, in contrast to a patient without the disease.
The (negative) LR (LR–) for absence of the symptom
is the odds that the test will be negative in a patient
with the disease, contrasted with a patient without the
disease. We aggregated or pooled LR values across
practices, as we have done in previous studies.14,15
It would be possible to analyse such relationships
between all possible combinations of episode titles and
RfEs, using the Transition Project databases.8,10 The
analysis was limited to two selected RfE examples for
practical reasons. The examples chosen were: (1) the
most common RfE in all four populations, i.e. ‘cough’
(ICPC code R05); and (2) an RfE from the mental
health (‘P’) chapter of ICPC which is a common
presenting symptom for a number of mental health
problems, i.e. the RfE ‘sadness’ or ‘feeling depressed’
(ICPC code P03).
In either case, data from each Transition Project
population database were analysed step-wise. We ﬁrst
identiﬁed episode titles which could potentially have a
signiﬁcant relationship with the index RfE, on the
basis that the diagnosis was frequently made in EoCs
with that RfE. This was done by analysing the 95%
conﬁdence interval (CI) of the rate (expressed as a rate
per 1000 observations) of all episode titles presenting
for that RfE. If the size of the observation was equiva-
lent to or larger than the width of the 95% CI of that
observation itself, the relationship was noted as one
which was potentially statistically signiﬁcant.1,14,16 All
such episode titles were selected for further analysis in
all four population databases. The next step was a
series of cross-tabulations of both the LR+ and the
LR–, performed one-way for the two RfEs against all
selected episode titles in each database. If the LRs for
all the cross-tabulations above were not clinically and
statistically signiﬁcant (see below) in all four databases,
that episode title was excluded from the selection as
not being signiﬁcantly associated with that RfE after all.
The minimum level of clinical signiﬁcance for an
LR was arbitrarily taken as that which represents a
standardised diﬀerence of at least 0.10 (10%).1,14–17
Cut-oﬀ levels of > 2 for the LR of a positive association
and < 0.5 for the LR of a negative association, were
thus taken as minimum thresholds for clinical signiﬁ-
cance.18–25 LRs outside these limits were considered
clinically insigniﬁcant. By contrast, LRs outside a
second arbitrary threshold (LR+ > 8, LR–<0.2) were
considered to indicate a strong diagnostic association,
and indicated as such in our conclusions if present
in more than one population. Furthermore, as above,
LRs which were not at least as large as their 95% CI
were considered unreliable.1,15–17,26 Furthermore, LRs
based on cells with very small numbers were ignored.
These criteria adjust for the increased chance of describ-
ing spurious associations due to the large numbers of
repeated statistical tests in this analysis process, and
also for the eﬀect of clustering of data on estimates of
variance.26
Results
Table 1 gives the incidence and prevalence rates of all
selected episode titles with a possible association with
the RfE ‘cough’ (ICPC code R05). The episode title
(ICPC code), and incidence and prevalence rates
expressed as EoCs per 1000 patient years of obser-
vation in the four populations (the Netherlands, Malta,
Serbia and Japan) are given. Such data are useful for
the calculation of the prior probability of an EoC in
the target population.11,16
In Table 2, the diagnostic associations are analysed.
The LR+ and LR– values for the RfE cough and all the
selected episode titles in the four populations are
listed. LRs are highlighted according to size (clinical
signiﬁcance) and reliability (95% CI). Strong predic-
tors (LR+ > 8 or LR–< 0.2, CI width smaller than or
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Table 1 Incidence and prevalence rates of all selected episode titles with a possible association with the reason for encounter (RfE) ’cough’
(ICPC code R05). The episode title, ICPC code, and incidence and prevalence rates expressed as EoCs per thousand patient years of observation
in the four populations (the Netherlands, Malta, Serbia and Japan) are given. The code for A92 (Allergy) is not available in ICPC-1 (the
Netherlands and Serbia), and the incidence and prevalence rates are thus not applicable (N/A)
Rates per 1000 patient years
(Episodes)
The Netherlands Malta Serbia Japan
Incidence Prevalence Incidence Prevalence Incidence Prevalence Incidence Prevalence
Cough (R05) 42.3 50.6 23.0 27.6 1.4 2.3 6.7 8.3
Acute bronchitis/bronchiolitis
(R78)
41.8 48.6 42.0 43.4 25.5 50.7 17.1 17.8
URTI head cold (R74) 50.5 53.7 202.0 205.7 47.2 99.5 292.3 298.4
Acute laryngitis/tracheitis
(R77)
13.9 15.0 16.8 17.8 4.3 7.7 2.0 2.2
Sinusitis (R75) 30.8 35.9 18.3 20.8 5.0 10.9 8.2 9.3
Pneumonia (R81) 9.4 10.7 1.8 2.2 1.5 2.5 5.6 6.9
Inﬂuenza (R80) 9.4 9.6 24.8 25.2 1.3 2.2 22.1 22.2
Asthma (R96) 6.7 40.9 12.1 39.3 0.7 4.0 6.6 20.7
Other viral disease NOS
(A77)
13.6 14.2 3.0 3.0 0.6 0.9 1.5 1.5
Whooping cough (R71) 1.8 2.0 0.2 0.3 0.2 0.3 0.1 0.1
Acute otitis media/myringitis
(H71)
19.8 21.2 11.5 12.1 2.0 3.1 4.6 4.7
Symptoms/complaints throat
(R21)
15.8 17.8 2.1 2.2 2.0 3.0 3.5 3.9
Tonsillitis (R76) 14.7 15.5 32.4 34.4 13.8 25.6 11.9 12.3
Adverse eﬀect medication
proper dose (A85)
30.7 35.8 14.5 20.8 0.1 0.2 7.7 8.2
In
te
rp
re
ta
tio
n
o
f
re
a
so
n
s
fo
r
e
n
co
u
n
te
r
in
fo
u
r
in
te
rn
a
tio
n
a
l
fa
m
ily
m
e
d
icin
e
p
o
p
u
la
tio
n
s
2
9
Table 1 Continued
Hayfever/allergic rhinitis
(R97)
8.8 38.7 10.0 25.4 0.4 0.7 10.6 16.1
Symptoms/complaints chest
(L04)
18.5 21.7 3.2 3.6 0.6 1.3 9.4 9.7
Hypertrophy tonsils/adenoids
(R90)
3.2 6.6 0.2 0.8 0.2 0.2 0.2 0.2
Shortness of breath/dyspnea
(R02)
6.0 7.6 0.5 0.7 0.4 0.6 1.1 1.3
Fever (A03) 6.1 6.4 3.6 3.9 0.6 0.7 7.6 8.1
COPD (R95) 1.5 11.0 0.2 0.9 1.5 6.6 1.2 4.5
General weakness/tiredness
(A04)
30.6 37.5 4.2 4.8 0.9 1.5 10.2 11.2
Chronic bronchitis (R91/R79) 0.5 2.4 0.5 1.3 4.7 19.3 0.9 4.2
Other respiratory symptoms/
complaints (R29)
0.6 0.7 23.6 24.4 0.2 0.5 0.2 0.3
Sneezing/nasal congestion
(R07)
3.0 4.4 6.0 7.2 0.1 0.1 0.7 0.9
Wheezing (R03) 0.7 0.8 1.4 1.8 0.1 0.3 0.1 0.2
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Table 1 Continued
Rates per 1000 patient years
(Episodes)
The Netherlands Malta Serbia Japan
Incidence Prevalence Incidence Prevalence Incidence Prevalence Incidence Prevalence
Presumed GI infection (D73) 15.3 15.9 79.6 80.6 5.7 10.0 30.8 31.0
Sputum/phlegm abnormal
(R25)
0.8 1.0 0.7 0.8 0.0 0.0 1.5 2.2
Strep throat (R72) 2.4 2.5 0.0 0.0 1.9 6.0 1.3 1.5
No disease (A97) 43.2 48.3 42.3 44.3 0.6 0.9 42.8 46.4
Allergy/allergic reaction NOS
(A92)
N/A N/A 4.0 5.4 0.8 1.2 N/A N/A
Health maintenance/
preventive medicine (A98)
97.9 171.4 90.4 111.6 4.5 5.3 2.3 2.6
Heart failure (K77) 3.5 14.4 2.0 5.1 2.7 14.3 3.6 13.1
Pleurisy/pleural eﬀusion (R82) 0.2 0.3 0.8 0.9 0.2 0.5 0.2 0.3
Muscle pain (L18) 7.3 11.1 40.5 45.0 0.2 0.4 2.3 2.9
Teeth/gum symptom/
complaint (D19)
2.5 2.7 3.6 3.7 0.2 0.3 0.8 0.8
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Table 2 Positive (LR+) and negative (LR-) likelihood ratios for the RfE cough for all the selected episode titles (label and ICPC code listed) in
the four populations. LRs are highlighted according to size (clinical signiﬁcance) and reliability (95% CI). Strong predictors (LR+ >8 or LR- <0.2,
CI width being equal to or smaller than the size of the observation itself) are in bold type. Weak predictors (LR+ >2–8, LR- 0.2–0.4, small CI)
are in italics. Associations with a wide CI (larger than the observation itself) or which are not clinically signiﬁcant (LR+ <=2, LR- >=0.5) or have
a CI which includes unity are not highlighted. The code for A92 (Allergy) is not available in ICPC-1 (the Netherlands and Serbia), and the
likelihood ratios are not applicable (N/A)
Rfe (R05) Cough
Episode title
The Netherlands Malta Serbia Japan
LR+ LR– LR+ LR– LR+ LR– LR+ LR–
Cough (R05) 20.3 (19.9–20.7) 0.2 (0.2–0.2) 7.2 (7.1–7.4) 0.1 (0.0–0.1) 12.8 (11.3–14.5) 0.3 (0.2–0.4) 8.1 (7.7–8.6) 0.1 (0.0–0.1)
Acute bronchitis/
bronchiolitis (R78)
16.2 (15.8–16.5) 0.3 (0.3–0.3) 5.6 (5.4–5.8) 0.3 (0.3–0.4) 11.0 (10.3–11.8) 0.6 (0.6–0.6) 5.9 (5.4–6.5) 0.4 (0.3–0.4)
URTI head cold (R74) 8.5 (8.2–8.7) 0.6 (0.6–0.6) 3.2 (3.0–3.3) 0.7 (0.7–0.8) 8.3 (7.8–9.0) 0.7 (0.7–0.7) 11.8 (10.9–12.8) 0.6 (0.6–0.6)
Acute laryngitis/
tracheitis (R77)
12.5 (12.1–12.9) 0.4 (0.3–0.4) 4.9 (4.6–5.2) 0.4 (0.3–0.4) 8.9 (7.9–1.0) 0.5 (0.5–0.6) 1.9 (1.1–3.6) 0.9 (0.7–1.1)
Sinusitis (R75) 2.8 (2.6–3.0) 0.9 (0.9–0.9) 1.6 (1.4–1.8) 0.9 (0.9–0.9) 2.7 (2.1–3.4) 0.9 (0.9–0.9) 1.3 (0.9–1.9) 1.0 (0.9–1.0)
Pneumonia (R81) 8.5 (8.0–9.0) 0.6 (0.5–0.6) 4.9 (4.3–5.7) 0.3 (0.2–0.5) 2.7 (1.8–4.2) 0.9 (0.8–1.0) 3.3 (2.6–4.2) 0.7 (0.6–0.8)
Inﬂuenza (R80) 6.3 (5.8–6.7) 0.7 (0.7–0.7) 3.1 (2.9–3.3) 0.7 (0.6–0.7) 4.7 (3.3–6.5) 0.8 (0.7–0.9) 2.3 (1.9–2.7) 0.8 (0.8–0.9)
Asthma (R96) 8.0 (7.4–8.5) 0.6 (0.6–0.6) 5.5 (5.2–5.7) 0.3 (0.2–0.3) 0.7 (0.2–2.6) 1.0 (1.0–1.1) 5.2 (4.5–6.0) 0.4 (0.3–0.5)
Other viral disease
NOS (A77)
2.5 (2.2–2.8) 0.9 (0.9–0.9) 0.1 (0.0–0.4) 1.2 (1.1–1.2) 4.8 (3.0–7.6) 0.8 (0.6–0.9) – –
Whooping cough
(R71)
14.5 (13.7–15.3) 0.2 (0.2–0.3) 5.9 (4.6–7.8) 0.2 (0.0–0.9) 2.6 (0.7–9.3) 0.9 (0.7–1.1) – –
Acute otitis media/
myringitis (H71)
0.8 (0.7–1.0) 1.0 (1.0–1.0) 0.3 (0.2–0.5) 1.1 (1.1–1.1) – – 0.5 (0.2–1.2) 1.1 (1.0–1.1)
Symptoms/
complaints throat
(R21)
0.7 (0.5–0.8) 1.0 (1.0–1.0) 0.2(0.0–0.6) 1.2 (1.1–1.2) 0.6 (0.2–1.4) 1.0 (1.0–1.1) 0.4 (0.1–1.2) 1.1 (1.0–1.2)
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Table 2 Continued
Rfe (R05) Cough The Netherlands Malta Serbia Japan
LR+ LR– LR+ LR– LR+ LR– LR+ LR–
Tonsillitis (R76) 0.6 (0.5–0.8) 1.0 (1.0–1.0) 0.5 (0.4–0.6) 1.1 (1.1–1.1) 1.0 (0.7–1.2) 1.0 (1.0–1.0) 0.7 (0.5–1.1) 1.0 (1.0–1.1)
Adverse eﬀect
medication proper
dose (A85)
0.2 (0.2–0.3) 1.1 (1.0–1.1) 0.3 (0.2–0.4) 1.1 (1.1–1.2) – – 1.3 (0.9–1.9) 1.0 (0.9–1.0)
Hayfever/allergic
rhinitis (R97)
0.7 (0.6–0.9) 1.0 (1.0–1.0) 1.8 (1.6–2.1) 0.9 (0.8–0.9) – – 0.1 (0.0–0.4) 1.1 (1.1–1.1)
Symptoms/
complaints chest
(L04)
0.3 (0.2–0.4) 1.0 (1.0–1.1) – – – – -- –
Hypertrophy tonsils/
adenoids (R90)
1.7 (1.3–2.2) 1.0 (0.9–1.0) – – 2.8 (0.8–9.9) 0.9 (0.7–1.1) – –
Shortness of breath/
dyspnea (R02)
0.9 (0.6–1.1) 1.0 (1.0–1.0) 0.7 (0.2–2.4) 1.1 (0.9–1.2) 1.1 (0.3–4.3) 1.0 (0.9–1.1) – –
Fever (A03) 0.8 (0.6–1.1) 1.0 (1.0–1.0) 0.1 (0.0–0.4) 1.2 (1.1–1.2) – – 0.1 (0.0–0.4) 1.1 (1.1–1.2)
COPD (R95) 3.2 (2.5–4.2) 0.9 (0.8–0.9) 2.7 (1.3–5.8) 0.7 (0.4–1.2) 1.8 (1.0–3.1) 1.0 (0.9–1.0) 2.1 (1.0–4.4) 0.9 (0.7–1.1)
General weakness/
tiredness (A04)
0.2 (0.1–0.2) 1.1 (1.1–1.1) 0.0 (0.0–0.3) 1.2 (1.2–1.2)
Chronic bronchitis
(R79/R91)
9.8 (8.0–12.1) 0.5 (0.4–0.6) 5.6 (4.6–6.8) 0.2(0.1–0.5) 2.9 (2.3–3.6) 0.9(0.8–0.9) 2.7 (1.3–5.6) 0.8 (0.5–1.1)
Other respiratory
symptoms/complaints
(R29)
0.4 (0.1–1.5) 1.0 (1.0–1.1) 4.8 (4.5–5.0) 0.4 (0.4–0.4) – – – –
Sneezing/nasal
congestion (R07)
0.5 (0.3–0.9) 1.0 (1.0–1.1) 1.6 (1.3–2.0) 0.9 (0.9–1.0) – – 0.7 (0.1–4.5) 1.0 (0.9–1.2)
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Table 2 Continued
Wheezing (R03) 3.3 (2.3–4.9) 0.9 (0.8–0.9) 4.2 (3.5–5.1) 0.5 (0.3–0.6) – – – –
Presumed GI
infection (D73)
0.1 (0.0–0.1) 1.1 (1.1–1.1) 0.1 (0.0–0.1) 1.2 (1.2–1.2) – – 0.1 (0.0–0.2) 1.1 (1.1–1.1)
Sputum/phlegm
abnormal (R25)
2.1 (1.3–3.4) 0.9 (0.9–1.0) 4.7 (3.7–5.9) 0.4 (0.2–0.6) – – – –
Strep throat (R72) 0.6 (0.3–1.0) 1.0 (1.0–1.1) – – 2.9 (2.0–4.2) 0.9 (0.8–1.0) 0.4 (0.1–2.4) 1.1 (1.0–1.2)
No disease (A97) 0.1 (0.0–0.1) 1.1 (1.1–1.1) 0.1 (0.0–0.1) 1.2 (1.2–1.2) 0.4 (0.1–2.7) 1.0 (1.0–1.1) 0.0 (0.0–0.1) 1.1 (1.1–1.2)
Allergy/allergic
reaction NOS (A92)
N/A N/A 0.7 (0.4–1.0) 1.1 (1.0–1.1) – – N/A N/A
Health maintenance/
preventive medicine
(A98)
0.0 (0.0–0.0) 1.1 (1.1–1.1) 0.0 (0.0–0.0) 1.2(1.2–1.2) – – – –
Heart failure (K77) 0.7 (0.5–1.1) 1.0 (1.0–1.0) 0.6 (0.3–1.2) 1.1 (1.0–1.1) 0.2 (0.0–0.7) 1.1 (1.0–1.1) 0.4 (0.1–1.2) 1.1 (1.0–1.2)
Pleurisy/pleural
eﬀusion (R82)
24.7 (2.2–272.3) 1.0 (1.0–1.0) 1.4 (0.8–2.8) 0.9 (0.8–1.1) 1.3 (0.2–8.5) 1.0 (0.8–1.2) – –
Muscle pain (L18) 0.1 (0.0–0.2) 1.1 (1.1–1.1) 0.0 (0.0–0.1) 1.2 (1.2–1.2) – – – –
Teeth/gum symptom/
complaint (D19)
0.0 (0.0–0.3) 1.1 (1.1–1.1) 0.3 (0.1–0.6) 1.1 (1.1–1.2)
" Black = not signiﬁcant (LR+ <=2,LR- >=0.5, or wide CI)"
" Italics = weak predictor (LR+ >2–8, LR- 0.2–0.4, small CI)"
" Bold = strong predictor (LR+ >8, LR- <0.2, small CI)"
equal to the LR itself) are in bold type. Weak predic-
tors (LR+ > 2–8, LR– 0.2–0.4, small CI) are in italics.
LRs with a wide CI (larger than the observation itself)
or which are not clinically signiﬁcant (LR+  2, LR–
 0.5) or have a CI which includes unity are not
highlighted.
The symptom ‘cough’ is a strong, reliable predictor
for the diagnoses ‘cough’ (a symptom diagnosis),
‘acute bronchitis’, ‘URTI’ and ‘acute laryngitis/tra-
cheitis’ in at least two populations. It is a less strong,
but reliable predictor of the diagnoses ‘sinusitis’,
‘pneumonia’, ‘inﬂuenza’, ‘asthma’, ‘other viral dis-
eases (NOS)’, ‘whooping cough’, ‘chronic bronchitis’,
‘wheezing’ and ‘phlegm’ with some exceptions, such
as the strong association in the Dutch database. The
absence of cough (as anRfE) is a less strong but reliable
predictor to exclude the diagnoses ‘cough’, ‘acute
bronchitis’ and ‘tracheitis’. Its presence allows strong
and reliable exclusion of the diagnoses ‘gastroenter-
itis’, ‘no disease’ and ‘health promotion/prevention’,
and less strong but reliable exclusion of the diagnosis
‘adverse eﬀects of medication’. There is less reliable
evidence that cough supports making a diagnosis of
‘COPD’, and supports the exclusion of ‘weakness/
tiredness’ ‘muscle pain’ and ‘teeth/gum complaints’
as a diagnosis, since the LRs are clinically signiﬁcant
but outside our CI limits in all but one population.
Table 3 gives the incidence and prevalence rates of
all selected episode titles with a possible association
with the RfE ‘sadness/feeling depressed’ (ICPC code
P03). The episode title, ICPC code, and incidence and
prevalence rates expressed as EoCs per 1000 patient
years of observation in the four populations (the
Netherlands, Malta, Serbia and Japan) are given.
Such data are useful for the calculation of the prior
probability of an EoC in the target population.11,16
In Table 4, the diagnostic associations are analysed.
The positive (LR+) and negative (LR–) likelihood
ratios for the RfE sadness for all the selected episode
titles in the four populations are listed. LRs are
highlighted according to size (clinical signiﬁcance)
and reliability (95% CI). Strong predictors (LR+ > 8
or LR–< 0.2, CI width being smaller than or equal to
the LR itself) are in bold type.Weak predictors (LR+>
2–8, LR– 0.2–0.4, small CI) are in italics. LRs with a
wide CI (larger than the observation itself) or which
are not clinically signiﬁcant (LR+  2, LR–  0.5) or
have a CI which includes unity are not highlighted.
The symptom ‘sadness’ is a strong, reliable predic-
tor for the symptom diagnosis ‘feeling sad/depressed’
and the diagnosis ‘depressive disorder’ in at least two
populations. It is a less strong, but reliable predictor of
the diagnosis ‘acute stress reaction’. The absence of
sadness (as a symptom) is a less strong but reliable
predictor to exclude the symptom diagnosis ‘feeling
sad/depressed’. Its presence does not support the
exclusion of any diagnosis in the populations studied.
In the Netherlands, ‘sadness’ is also a strong, reliable
predictor for the diagnoses ‘anxiety disorder’ and
‘neurasthenia’, and a weak but reliable predictor for
the diagnoses ‘feeling anxious’ and ‘relationship prob-
lems with partner’. TheMaltese LRs, and one Serb LR,
are similar, but have wider CIs which do not allow a
stronger conclusion on the association.
Discussion
Principal ﬁndings
This is a study of the clinical interpretation of two
common symptom RfEs, ‘cough’ and ‘sadness’, in
routine family practice in four practice populations.
Data collected with ICPC were used to analyse the
diagnostic associations between these two RfEs and
diagnoses made during the ﬁrst encounter of an EoC
starting with their presentation to the FD. A number
of positive and negative diagnostic associations were
found between these two RfEs and a number of
episode titles. These associations were found to have
diﬀerent strengths of eﬀect and diﬀering precision of
the eﬀect estimate. However, several diagnostic as-
sociations were found to be similar in two or more of
the databases. A larger database would have given
more precise LR estimates, and would likely have
demonstrated even more congruence between these
diagnostic associations.
Implications of the ﬁndings
This study presents diagnostic associations from the
perspective of the RfE, making it particularly useful to
clinicians dealing with diagnostic challenges in the
form of a newly presenting symptom in their daily
practice. There weremore similarities than diﬀerences
in the diagnostic associations between RfEs and epi-
sode titles across populations, especially evidenced by
the more frequent observations with narrower CIs.
Comparisons with the literature
The relative lack of symptoms-oriented research into
the diagnostic process in primary care makes ﬁnding
comparable literature challenging. Most studies of
diagnostic associations have been performed in data-
sets which are not exclusively or mainly from primary
care. Additionally, most study a disease label diagnosis
and its associations with symptoms and test results as
predictors, and not the other way around.18–25 Even
then, the small values proposed for LRs, for example,
JK Soler, I Okkes, S Oskam et al34
In
te
rp
re
ta
tio
n
o
f
re
a
so
n
s
fo
r
e
n
co
u
n
te
r
in
fo
u
r
in
te
rn
a
tio
n
a
l
fa
m
ily
m
e
d
icin
e
p
o
p
u
la
tio
n
s
3
5
Table 3 Incidence and prevalence rates of selected episode titles with a possible association with the RfE ’sadness/feeling depressed’ (ICPC
code P03). The episode title, ICPC code, and incidence and prevalence rates expressed as EoCs per thousand patient years of observation in the
four populations (the Netherlands, Malta, Serbia and Japan) are given
Rates per 1000 patient years
(Episodes)
The Netherlands Malta Serbia Japan
Incidence Prevalence Incidence Prevalence Incidence Prevalence Incidence Prevalence
Feeling depressed (P03) 5.2 7.4 1.8 2.5 0.4 1.2 0.1 0.2
Depressive disorder (P76) 10.1 36.1 6.7 21.4 2.4 9.7 1.6 5.2
General weakness/tiredness
(A04)
30.6 37.5 4.2 4.8 0.9 1.5 10.2 11.2
Acute stress reaction (P02) 5.8 7.9 4.2 5.4 0.7 1.6 0.1 0.1
Feeling anxious/nervous/tense
(P01)
12.7 29.8 7.5 12.8 4.4 14.1 1.9 4.4
"Neurasthenia, surmenage
(P78)"
4.1 6.1 0.0 0.0 0.2 0.5 0.0 0.0
Anxiety disorder/anxiety state
(P74)
2.0 8.8 3.8 14.7 19.1 60.5 1.8 5.2
Relationship problem with
partner (Z12)
4.8 6.9 1.4 3.6 0.0 0.0 0.0 0.0
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Table 4 Positive (LR+) and negative (LR–) likelihood ratios for the RfE sadness for all the selected episode titles (label and ICPC code listed) in
the four populations. LRs are highlighted according to size (clinical signiﬁcance) and reliability (95% CI). Strong predictors (LR+ >8 or LR– <0.2,
CI width being equal to or smaller than the size of the observation itself) are in bold type. Weak predictors (LR+ >2–8, LR– 0.2–0.4, small CI)
are in italics. Associations with a wide CI (larger than the observation itself) or which are not clinically signiﬁcant (LR+ <=2, LR– >=0.5) or have
a CI which includes unity are not highlighted
Rfe (P03)
Feeling
depressed
Episode title
The Netherlands Malta Serbia Japan
LR+ LR– LR+ LR– LR+ LR– LR+ LR–
Feeling
depressed (P03)
292.8 (269.4–
318.2)
0.3 (0.3–0.3) 146.1 (116.5–
183.2)
0.4 (0.3–0.5) 252.8 (92.1–693.8) 0.9 (0.8–1.0) 2279.6 (442.3–
11749.4)
0.5 (0.1–2.0)
Depressive
disorder (P76)
108.6 (98.1–120.1) 0.7 (0.7–0.7) 188.1(152.7–231.8) 0.5 (0.5–0.6) 112.8 (49.4–257.9) 1.0 (0.9–1.0) 4216.9 (509.4–
34908.4)
0.8 (0.7–1.0)
General
weakness/
tiredness (A04)
1.9 (1.4–2.6) 1.0 (1.0–1.0) 2.2 (0.6–8.9) 1.0 (1.0–1.0) – – – –
Acute stress
reaction (P02)
8.0 (5.6–11.5) 1.0 (1.0–1.0) 41.2 (29.3–57.8) 0.8 (0.8–0.9) – – – –
Feeling anxious/
nervous/tense
(P01)
3.5 (2.4–5.1) 1.0 (1.0–1.0) 9.3 (5.5–15.8) 1.0 (0.9–1.0) – – – –
00Neurasthenia,
surmenage
(P78)00
10.4 (7.2–15.2) 1.0 (1.0–1.0) – – – – – –
Anxiety
disorder/anxiety
state (P74)
12.5 (7.8–20.3) 1.0 (0.9–1.0) 10.1 (5.1–20.2) 1.0 (0.9–1.0) 19.1 (8.6–42.5) 1.0 (1.0–1.0) – –
Relationship
problem with
partner (Z12)
5.3 (3.3–8.6) 1.0 (1.0–1.0) 14.2 (5.5–36.8) 1.0 (0.9–1.0) – – – –
Black = not signiﬁcant (LR+ <=2,LR- >=0.5, or wide CI)
" Italics = weak predictor (LR+ >2–8, LR- 0.2–0.4, small CI)"
" Bold = strong predictor (LR+ >8, LR- <0.2, small CI)"
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for the symptom cough and the diagnoses inﬂuenza
and community acquired pneumonia18,20 make one
wonder whether they may be generalised to primary
care populations. For example, it is diﬃcult to accept
the conclusion that no symptom has a clinically sig-
niﬁcant (deﬁned as an LR of > 2 or < 0.5) predictive
value for either inﬂuenza or pneumonia in the general
population.18,20 Clinicians routinely diagnose such
diseases on the basis of symptoms for which these
articles have failed to ﬁnd a diagnostic association, and
many medical textbooks describe relationships be-
tween symptoms and such diseases.
In that sense, the diagnostic associations we have
found may be more acceptable to and useful for
clinicians. Furthermore, the congruency (and often
statistical consistency) of diagnostic associations be-
tween these populations, and especially the fact that
most of them are in the same direction from unity,
sustain our conﬁdence in their validity.14,15 Addition-
ally, the fact that we also present incidence and
prevalence rates in these populations allows one to
calculate prior and posterior probabilities for these
diagnostic entities.
Limitations
This study was based on practice populations, col-
lecting data from actual consultations with the FD.
The strength of such empiricism is balanced by the
limitation that we did not have data on the actual
prevalence and incidence of illness at a community
level. We analysed data on EoCs, rather than episodes
of illness, in the community.
This study examined associations between RfEs and
episode titles at the beginning of a new EoC for that
problem. It is quite possible that the diagnosis may
have been revised over time during another consul-
tation forming part of the EoC due to a change in the
presentation, or a change in the diagnostic opinion of
the FD, or consequent to the results of further testing,
or through an opinion expressed by another health-
care provider, or otherwise. In such cases, the ﬁrst
diagnosismade at the start of the EoCwould have been
revised at a later consultation within the episode. A
diﬀerent analysis andmethodology would be required
to capture that transition in the diagnosis, and this is
planned for a future study. However, transitions in
diagnoses represent a small proportionof EoCs, and in
many cases the ﬁrst diagnosis is the one that persists
until the end of the EoC. Nevertheless, the LRs we
report should be interpreted with this limitation in
mind.
It is possible that the RfEs cough and sadness may
have an important eﬀect in increasing the probability
of a serious illness to a small but clinically signiﬁcant
degree. In such a case, it is possible that we could miss
such an eﬀect due to our strict clinical and statistical
limits, and the size limitations of our databases. For
example, if the ﬁrst presentation of the RfE ‘cough’
slightly increases the probability of a serious and
potentially life-threatening disease such as lung cancer,
then even such a small eﬀect might have important
clinical consequences in a smallminority of patients. It
is also possible that strong but infrequent associations
were not picked up, since we ignored observations
based on very small numbers. As such, these data
should not be interpreted as supporting the exclusion
of serious illness simply on the basis of lack of evidence
of diagnostic association with an RfE. The only diag-
nostic exclusions we would support with these data
are those supported by clinically and statistically
signiﬁcant LRs. In any case, the clinical acumen of
an experienced FD cannot be entirely summarised by
these data, which oﬀer an important insight into
clinical decisionmaking, butdonot in anyway replace it.
A larger dataset would have quite likely picked up
more signiﬁcant associations, andprovidedmoreprecise
estimates of eﬀects. We expect that a larger dataset
would have evidenced similar associations between
‘sadness’ and ‘anxiety disorder’ and ‘relationship prob-
lem with partner’ in both the Dutch and Maltese
datasets, and allowed stronger conclusions to be drawn
about both positive and negative diagnostic associ-
ations between ‘cough’ and a number of episode titles
in more populations. The observed diﬀerences in diag-
nostic associations between populations may thus be
due more to the lack of power to deﬁne the LRs more
precisely, rather than due to any real diﬀerence in
diagnostic processing of such RfEs.
The use of the EoC data model allows more precise
estimates of incidence and prevalence rates, which is a
considerable strength.3,11 However, many information
systems do not allow episode type coding, or do not
allow the analysis of diagnostic data structured in
EoCs even though the datum may be coded. Thus,
replicating this study may be diﬃcult with other
datasets.
We have pooled data from diﬀerent FD practices
and across an observation period spanning a number
of years. This may open our analyses to criticisms
based on the relative size of the interdoctor and inter-
practice variation compared with variation between
populations. We have studied this phenomenon and
published our results elsewhere.15 The eﬀect of inter-
practice variation is in fact relatively small, and our
research leads us to advocate the use of such pooled
data. A larger pooled dataset allows much more precise
estimations of diagnostic associations as against data
from one practice or one year of observation, and the
eﬀect of interpractice variation is small enough to be
ignored.15
There is a challenge in combining information from
diﬀerent populations to produce an ‘international’
interpretation of a diagnostic association between a
symptom and a diagnosis, or more precisely an RfE and
an episode title. We understand the limitations of our
interpretation of the diagnostic associations in this
study, butwe defend our approach.Wehereby publish
the LRs used to study and describe these diagnostic
associations in four diﬀerent populations, and we
oﬀer our interpretation of the strength and reliability
of such diagnostic associations, summarising the em-
pirical data in text form. We understand that others
may interpret these data diﬀerently, or may choose to
accept diﬀerent limits for the clinical and statistical
signiﬁcance of such associations.
Strengths
This is a study of diagnostic associations for two
common symptoms in practice populations in very
diﬀerent healthcare settings, which has the advantage
of empirical data collection and the validation of
observations between four independent datasets. We
present these diagnostic data along with associated
incidence and prevalence rates which allow one to
calculate prior and posterior probabilities for these
diagnostic entities in these populations. We collected
data on all RfEs presented and all diagnoses made in
EoCs, which allows one to study any possible diag-
nostic association and deﬁne those that reach clinical
and statistical signiﬁcance. The presented data are but
two examples. We also applied tight clinical and stat-
istical signiﬁcance limits to avoid describing spurious
associations. The congruency of the diagnostic associ-
ations across populations sustains our conﬁdence in
their validity.
Call for further research
Further research in this area is important to sustain the
development of FM as a clinical and academic disci-
pline, and to inform decision-support tools and sys-
tems developed for family practice. The assumptions
we have made on the clinical and statistical signiﬁcance
limits for a diagnostic association, and the method we
have used to interpret and summarise such diagnostic
associations in diﬀerent populations, are presented to
the scientiﬁc community for discussion.
Conclusions
We describe clinically and statistically signiﬁcant di-
agnostic associations observed between the RfEs ‘cough’
and ‘sadness’, presenting as a new problem in family
practice in four populations, and all the episode titles
in ICPC.
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